$15 million in Series B investment was received by Livara Health, a value-based musculoskeletal (MSK) management firm situated in San Diego, California (previously known as SpineZone).
Investors
- A1 Health Ventures (led the investment)
- previous investors Polaris
- Partners, Providence
- Ventures, Martin
- and a new strategic
With this cash, the company’s clinical expertise and technological innovation will pick up speed.
Livara Health is a value-based MSK management solution for creative providers, payors, utilization management firms, and value-based health systems, and it is led by CEO Rob Cohen.
Livara collaborates with commercial and Medicare payors and providers through value-based payment agreements, which include taking on the whole cost of MSK care, by integrating care planning, virtual first care delivery, and care navigation.
Since its creation, Livara has treated more than 120,000 patients. As of 2024, around 4 million individuals, including Medicare and commercially insured populations, are able to use its MSK management platform through agreements with health plans and providers.
About Livara Health
Livara Health is a holistic, value-based musculoskeletal care solution for innovative healthcare payors and providers. By combining high-touch, multidisciplinary care teams, advanced technology, and seamless integration with local providers, It has delivered exceptional patient outcomes for over 15 years. When compared to traditional conservative treatment options, Livara’s patients require fewer surgeries, injections, and opioids. Livara partners with fully insured commercial and Medicare Advantage payors and providers, including AIM, Elevance, Scripps, and Providence St. Joseph Health, through flexible value-based payment arrangements, including assuming total cost of MSK care. With a 94 patient net promoter score, it is transforming MSK care.
